PAPER Henrique D, Bally-Cuif L
SEARCH RESULTS
329960 RESULTS
PAPER Warby SC, Visscher H, Butland S, Pearson CE, Hayden MR
Response to Falush: a role for cis-element polymorphisms in HD.
Am J Hum Genet. 2009 Dec;85(6):942-5. PubMed: 20004773PAPER Jawaid A, Murthy SB, Wilson AM, Qureshi SU, Amro MJ, Wheaton M, Simpson E, Harati Y, Strutt AM, York MK, Schulz PE
A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS.
Amyotroph Lateral Scler. 2010 Dec;11(6):542-8. PubMed: 20500116PAPER Xu X, Kedlaya R, Higuchi H, Ikeda S, Justice MJ, Setaluri V, Ikeda A
Mutation in archain 1, a subunit of COPI coatomer complex, causes diluted coat color and Purkinje cell degeneration.
PLoS Genet. 2010 May;6(5):e1000956. PubMed: 20502676PAPER Fu Q, Dai H, He P, Hu W, Fan Y, Zhang W, Chen Z
The H3 receptor antagonist clobenpropit protects against Abeta42-induced neurotoxicity in differentiated rat PC12 cells.
Pharmazie. 2010 Apr;65(4):257-60. PubMed: 20432621ApoE and Brain Networks—The Anatomy of a Risk Factor
RESEARCH NEWS 2010-05-28 Research News Clinicians have long puzzled over the heterogeneity of Alzheimer disease symptoms—for example, some patients display the classic disorientation and forgetfulness, whereas others struggle more with planning and organization. A PNAS paper publ
PAPER Jiao W, McDonald DQ, Coxon JM, Parker EJ
Molecular modeling studies of peptide inhibitors highlight the importance of conformational prearrangement for inhibition of calpain.
Biochemistry. 2010 Jul 6;49(26):5533-9. PubMed: 20499928PAPER Alvarez XA, Cacabelos R, Sampedro C, Aleixandre M, Linares C, Granizo E, Doppler E, Moessler H
Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin.
Eur J Neurol. 2011 Jan;18(1):59-68. PubMed: 20500802PAPER Kornhuber J, Tripal P, Reichel M, Mühle C, Rhein C, Muehlbacher M, Groemer TW, Gulbins E
Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications.
Cell Physiol Biochem. 2010;26(1):9-20. PubMed: 20502000PAPER Barca ML, Engedal K, Selbaek G
A reliability and validity study of the cornell scale among elderly inpatients, using various clinical criteria.
Dement Geriatr Cogn Disord. 2010;29(5):438-47. PubMed: 20502018PAPER Alexopoulos P, Ebert A, Richter-Schmidinger T, Schöll E, Natale B, Aguilar CA, Gourzis P, Weih M, Perneczky R, Diehl-Schmid J, Kneib T, Förstl H, Kurz A, Danek A, Kornhuber J
Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
Dement Geriatr Cogn Disord. 2010;29(5):448-56. PubMed: 20502019PAPER Reis HJ, Mukhamedyarov MA, Rizvanov AA, Palotás A
A new story about an old guy: is Alzheimer's disease infectious?
Neurodegener Dis. 2010;7(4):272-8. PubMed: 20502038PAPER Filbey FM, Chen G, Sunderland T, Cohen RM
Failing compensatory mechanisms during working memory in older apolipoprotein E-epsilon4 healthy adults.
Brain Imaging Behav. 2010 Jun;4(2):177-88. PubMed: 20502990PAPER
Disease-modifying drug fails in Alzheimer's study.
Brain Imaging Behav. 2010 Mar;4(1):46-54. PubMed: 20503478PAPER Bijland S, Pieterman EJ, Maas AC, van der Hoorn JW, van Erk MJ, van Klinken JB, Havekes LM, van Dijk KW, Princen HM, Rensen PC
Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.
J Biol Chem. 2010 Aug 13;285(33):25168-75. PubMed: 20501652Current Filters
No filters selected